Biodesix Inc.
BDSX | NASDAQ
$28.79
+$0.36 (+1.27%)
Sep 22, 2026, 1:47 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 88.5M | 71.32M | 49.09M | 38.21M | 54.51M | 45.56M |
Cost of Revenue | 16.72M | 15.57M | 13.01M | 14.15M | 30.52M | 22M |
Gross Profit | 71.78M | 55.75M | 36.08M | 24.06M | 23.99M | 23.56M |
Operating Income | -27.77M | -34.5M | -41.34M | -50.59M | -40.94M | -22.93M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -35.27M | -42.93M | -52.15M | -65.45M | -43.16M | -31.35M |
Net Income | -35.27M | -42.93M | -52.15M | -65.45M | -43.16M | -31.35M |
Selling & General & Admin | 87.55M | 80.45M | 67.39M | 61.46M | 50.52M | 34.86M |
Research & Development | 12M | 9.56M | 9.99M | 13.1M | 12.79M | 10.82M |
Other Expenses | n/a | 238K | 44K | 81K | 1.62M | 818K |
Operating Expenses | 99.55M | 90.25M | 77.42M | 74.65M | 64.93M | 46.49M |
Interest Expense | 7.72M | 8.26M | 9.54M | 8.07M | 4.51M | 7.6M |
Selling & Marketing Expenses | n/a | n/a | n/a | 61.46M | 50.52M | 34.86M |
Cost & Expenses | 116.27M | 105.82M | 90.43M | 88.8M | 95.45M | 68.49M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 7.55M | 6.48M | 4.11M | 2.11M | 1.37M | 1.33M |
Shares Outstanding (Diluted) | 7.55M | 6.48M | 4.11M | 2.11M | 1.37M | 1.33M |
EPS (Basic) | -4.67 | -6.62 | -12.70 | -31.09 | -31.54 | -23.61 |
EPS (Diluted) | -4.67 | -6.62 | -12.70 | -31.09 | -31.54 | -23.61 |
EBITDA | -21.95M | -29.22M | -37.1M | -51.53M | -35.47M | -20.84M |
EBIT | -27.55M | -34.67M | -42.61M | -57.38M | -38.65M | -23.75M |
Depreciation & Amortization | 5.6M | 5.46M | 5.51M | 5.84M | 3.18M | 2.9M |
Add to Watchlist
Select watchlists to add or remove BDSX